Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Highly potent, non-thiol-containing FTase inhibitor characterized by BMS at AACR meeting

April 10, 2000

Abbott designs macrolide LHRH antagonists

April 10, 2000

Hybridon presents preclinical results with MDM2 antisense compound at AACR

April 10, 2000

Nonsecosteroidal, nonhypercalcemic VDR agonist with antitumor activity designed at Ligand

April 7, 2000

Positive preclinical data obtained for naked DNA prostate cancer vaccine

April 7, 2000

NewBiotics completes private placement and prepares to advance study of lead product

April 7, 2000

Novel tumor-targeting approach taken by McGill scientists using chimeric molecules

April 7, 2000

Recent patent covers Merck's new tyrosine kinase inhibitors

April 7, 2000

Biological effects of SU-9516, a cdk inhibitor, studied in human colon cancer cells

April 7, 2000

Updated results from G-3139 clinical trial demonstrate durable response and survival

April 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...